个人简介
Domenico Tamburrino是IRCCS圣拉斐尔科学研究医院胰腺外科主任医师,在Massimo Falconi教授的指导下开展工作。
2008年,Tamburrino医生获得罗马生物医学大学医学文凭,2015年获得维罗纳大学普通外科专业学位。2020年,获得罗马大学消化道肿瘤学博士学位。
Tamburrino医生专攻肝胆胰腺相关肿瘤疾病,
以主刀医生的身份共完成约500台手术,主要涉及广泛性腹部手术(含微创技术)。在英国进修期间,他开始独立实施肝胆胰管肿瘤的外科治疗。他擅长利用在肝脏移植领域积累的丰富经验,进行复杂的动脉和静脉血管吻合术。
其主要研究领域包括:胰腺和胃肠道的外分泌和内分泌肿瘤;胰腺手术后的并发症。
Tamburrino医生是下列科学协会的成员:意大利胰腺研究协会(AISP)、欧洲神经内分泌肿瘤学会(ENETS)、欧洲胰腺俱乐部(EPC)、ItaNET、大不列颠及爱尔兰神经内分泌肿瘤学会(E-AHPBA)、欧洲非洲肝胆胰协会(SPIGC)
他还是意大利青年外科医师协会的理事会成员。
他以作者或共同作者的身份在意大利国内外期刊上发表了30篇科研论文。H指数为14。他经常参加意大利国内外的行业会议并发言。
出版物
最新出版物
Time to CA19.9 nadir: a clue for defining treatment duration of primary chemotherapy in resectable PDAC.
Ann Oncol. 2019 Jul;30 Suppl 4:iv111. doi: 10.1093/annonc/mdz156.003.
Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition.
Cells. 2019 Dec 28;9(1). pii: E83. doi: 10.3390/cells9010083.
Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis.
Inflamm Bowel Dis. 2019 Oct 18;25(11):1740-1750.
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens.
Neuroendocrinology. 2019;109(2):165-170.
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life.
Surgery. 2019 Aug;166(2):157-163.
Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for 2 Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma.
Pancreas. 2019 Apr;48(4):504-509.
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases.
HPB (Oxford). 2018 Mar;20(3):197-203.
Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.
Eur J Surg Oncol. 2018 Jan;44(1):24-30.
Major postoperative complications after pancreatic resection for P-NETS are not associated to earlier recurrence.
Eur J Surg Oncol. 2017 Nov;43(11):2119-2128.
Active Surveillance Beyond 5 Years Is Required for Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms Undergoing Non-Operative Management.
Am J Gastroenterol. 2017 Jul;112(7):1153-1161.
Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).
Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):65-73.
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
Cochrane Database Syst Rev. 2016 Sep 15;9:CD011515.
Surgical management of neuroendocrine tumors.
Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):93-102.
Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2 cm in MEN1 Patients.
Neuroendocrinology. 2016;103(6):779-86.
Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
Neuroendocrinology. 2015;102(1-2):68-76.